Pediatric Multisystem Syndrome Associated with SARS-CoV-2 (MIS-C): The Interplay of Oxidative Stress and Inflammation

Int J Mol Sci. 2022 Oct 25;23(21):12836. doi: 10.3390/ijms232112836.

Abstract

Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (MIS-C) is characterized by persistent fever and evidence of single or multiorgan dysfunction, and laboratory evidence of inflammation, elevated neutrophils, reduced lymphocytes, and low albumin. The pathophysiological mechanisms of MIS-C are still unknown. Proinflammatory mediators, including reactive oxygen species and decreased antioxidant enzymes, seems to play a central role. Virus entry activates NOXs and inhibits Nrf-2 antioxidant response inducing free radicals. The biological functions of nonphagocytic NOXs are still under study and appear to include: defense of epithelia, intracellular signaling mechanisms for growth regulation and cell differentiation, and post-translational modifications of proteins. This educational review has the aim of analyzing the newest evidence on the role of oxidative stress (OS) in MIS-C. Only by relating inflammatory mediators to OS evaluation in children following SARS-CoV-2 infection will it be possible to achieve a better understanding of these mechanisms and to reduce long-term morbidity. The link between inflammation and OS is key to developing effective prevention strategies with antioxidants to protect children.

Keywords: COVID-19; MIS-C; oxidative stress.

Publication types

  • Review

MeSH terms

  • Antioxidants / therapeutic use
  • COVID-19* / complications
  • Child
  • Humans
  • Inflammation
  • Oxidative Stress
  • SARS-CoV-2*
  • Syndrome

Substances

  • Antioxidants

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related

Grants and funding

This research received no external funding.